Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • gary
    Member
    • Dec 2009
    • 16

    MarkDuplicates result

    Hello everyone!

    My MarkDuplicates result looks like this:
    LIBRARY UNPAIRED_READS_EXAMINED READ_PAIRS_EXAMINED UNMAPPED_READS UNPAIRED_READ_DUPLICATES READ_PAIR_DUPLICATES READ_PAIR_OPTICAL_DUPLICATES PERCENT_DUPLICATION ESTIMATED_LIBRARY_SIZE
    TSC_3 351087 23255402 695866 192406 1108098 370488 0.051398 347340970

    ## HISTOGRAM java.lang.Double
    BIN VALUE
    1.0 1.015653
    2.0 1.965532
    3.0 2.853897
    4.0 3.68473
    5.0 4.461759
    6.0 5.188466
    7.0 5.868112
    8.0 6.503743
    9.0 7.098211


    My question is:
    what does the ESTIMATED_LIBRARY_SIZE mean?
    Picard's help info is: ESTIMATED_LIBRARY_SIZE: The estimated number of unique molecules in the library based on PE duplication.
    But I still can't understand.
    Last edited by gary; 10-16-2012, 07:17 PM.
  • davidblaney
    Member
    • Nov 2011
    • 18

    #2
    The Estimated number of unique fragments in your sequenced library.

    it uses this (from the API documentation)


    Estimates the size of a library based on the number of paired end molecules observed and the number of unique pairs ovserved. Based on the Lander-Waterman equation that states: C/X = 1 - exp( -N/X ) where X = number of distinct molecules in library N = number of read pairs C = number of distinct fragments observed in read pairs

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...